Market Overview

U.S. Major Depressive Disorder (MDD) Market Analysis & Outlook 2018-2022 - Players Featured are Pfizer, AstraZeneca, Eli Lilly & Company, and Lundbeck - ResearchAndMarkets.com

Share:

The "U.S.
Major Depressive Disorder (MDD) Market: Industry Analysis & Outlook
(2018-2022)"
report has been added to ResearchAndMarkets.com's
offering.

The report provides an extensive research and detailed analysis of the
present market along with future outlook. The report discusses the major
growth drivers and challenges of the market, covering the U.S. market.

The rising prevalence of major depression has led to a sharp increase in
the patient volume suffering from depression. Currently, many treatments
and therapies are available for major depression but the market still
holds a large scope of growth opportunities with high unmet needs of the
market.

MDD is the most common mental disorder in the U.S. Approximately 16
million American adults suffer from the major depressive disorder and
about one-third of the MDD patient remain untreated. The number of
treated patients is projected to rise on account of better medical
access and rising awareness regarding depression.

There are few potential drugs in development that are being developed
with improved efficacy and safety for the treatment of MDD and are
expected to contribute significantly to the market growth in the U.S.

Market Dynamics

Growth Drivers

  • Growing Aging Population
  • Rising Female Population
  • Increasing Spending on Prescription Drugs
  • Increasing Prevalence of Depression
  • Growing Mental Health Expenditure
  • Unmet Need

Key Trends & Developments

  • Increasing Awareness for Depression
  • Direct to Customer Advertising
  • Rapid Acting Drugs In Development
  • Rising Number of Mental Health Programs

Challenges

  • Stringent Drug Regulations
  • Patent Expiry of Drugs
  • Complications and Side Effects associated with Anti-depressants
  • Availability of Other Therapies such as Meditation and Psychotherapy

Key Topics Covered

1. Market Overview

2. The U.S. MDD Market

3. Market Dynamics

4. Competitive Landscape

5. Company Profiles

  • Pfizer Inc.
  • AstraZeneca
  • Eli Lilly & Company
  • Lundbeck

For more information about this report visit https://www.researchandmarkets.com/research/3hp8cs/u_s_major?w=4

View Comments and Join the Discussion!